C9 - complement C9 Gene

生物種: Bos taurus

遺伝子タイプ: protein coding
遺伝子ID: 526766

C9 Products (1)

mRNA Protein Name
NM_001035364.2 NP_001030441.1 complement component C9 precursor
Protein Preferred Names Protein Names

complement component C9

  • complement component 9

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (16)
製品番号 製品名 製品効果
純度 Rare Diseases
HY-17356 Fenofibrate 99.97% Yes
HY-B0113 Omeprazole Inhibitor 99.96% Yes
HY-N6972 Cepharanthine 99.87% Yes
HY-B1218 Sulfaphenazole Inhibitor 99.85% Unkown
HY-B0258 Gemfibrozil 99.91% Yes
HY-11103 Sitaxsentan sodium 98.83% Unkown
HY-100386 Ticlopidine Inhibitor 99.74% Unkown
HY-B0113A Omeprazole sodium Inhibitor 99.10% Yes
HY-13463 Avatrombopag Agonist 99.83% Yes
HY-B0153A Ticlopidine hydrochloride Inhibitor 99.99% Unkown
HY-13463A Avatrombopag maleate 99.99% Yes
HY-B0113R Omeprazole (Standard) Inhibitor 99.86% Unkown
HY-13463B Avatrombopag hydrochloride Agonist 97.05% Yes
HY-76520 Sitaxsentan 98.96% Unkown
HY-109546 Omeprazole magnesium Inhibitor / Unkown
HY-111654 Diflucortolone / Unkown

Clinical Phase

Bioactive Molecules (9)
製品番号 製品名 製品効果
純度 Phase
HY-132581 Tadnersen Inhibitor 99.30% Phase 3
HY-121872 DP-b99 Inhibitor 95.0% Phase 3
HY-N1201 Apigenin 99.22% Phase 2
HY-106379 Lurosetron Antagonist / Phase 2
HY-19397 BMS-223131 / Phase 2
HY-15565 APD668 99.73% Phase 1
HY-15566 APD597 Agonist 99.97% Phase 1
HY-114415 AWZ1066S Inhibitor 98.64% Phase 1
HY-12946A BI 653048 phosphate Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (239)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-N0904 Ginsenoside C-K Inhibitor 99.93% Unkown
HY-N0893 Tetrahydrocurcumin 98.96% Unkown
HY-15550 4'-Hydroxy diclofenac 99.70% Unkown
HY-N0043 Ginsenoside Rd Inhibitor 99.88% Unkown
HY-15550S 4'-Hydroxy diclofenac-d4 98.92% Unkown
HY-W013268 (S)-(+)-N-3-Benzylnirvanol Inhibitor 99.76% Unkown
HY-103661 BI-6C9 Inhibitor 98.47% Unkown
HY-N0762 Isobavachin 99.88% Unkown
HY-N1446S Oleic acid-13C 99.99% Unkown
HY-D1422 ER Tracker Yellow 96.91% Unkown
HY-114759 MS-PPOH Inhibitor 99.05% Unkown
HY-117026 LKY-047 Inhibitor 99.94% Unkown
HY-153898 rTRD01 Ligand 99.10% Unkown
HY-100738 Ubiquitin Isopeptidase Inhibitor I, G5 Inducer 98.0% Unkown
HY-N0473S3 L-Tyrosine-13C9 99.81% Unkown
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% Unkown
HY-100641 4-Hydroxytolbutamide 99.69% Unkown
HY-N1201R Apigenin (Standard) 98.82% Unkown
HY-170538 SNT-5382 Inhibitor 99.96% Unkown
HY-18063 ML252 Inhibitor 99.9% Unkown
HY-117389 Homocarbonyltopsentin 99.82% Unkown
HY-W140827 Boc-C9-Br / Unkown
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.42% Unkown
HY-N0920 Dihydrokavain Inhibitor 99.94% Unkown
HY-B0158S7 Cytidine-13C9 Chemical 98.69% Unkown
HY-W013175S2 Uridine 5'-monophosphate-13C9,15N2 disodium Activator 99.77% Unkown
HY-139345 (S,R,S)-AHPC-CO-C9-acid Chemical 95.00% Unkown
HY-N1050 Zederone Inhibitor 99.61% Unkown
HY-100641S 4-Hydroxytolbutamide-d9 99.29% Unkown
HY-132581A Tadnersen sodium Inhibitor 99.30% Unkown
HY-42034 Hydroquinine 99.87% Unkown
HY-W751165 Uridine-13C9,15N2 98.88% Unkown
HY-113359AS2 Uridine 5'-diphosphate-13C9,15N2 dilithium Agonist 99.15% Unkown
HY-125818S3 Cytidine-5'-triphosphate-13C9 dilithium 98.02% Unkown
HY-14362 GSK-25 Inhibitor 98.33% Unkown
HY-148822 Nampt activator-2 Activator 98.79% Unkown
HY-N0911 Rehmannioside A 99.95% Unkown
HY-W108995 Boc-C9-COOH ≥97.0% Unkown
HY-128859 EMT inhibitor-2 Inhibitor 98.83% Unkown
HY-B1449S11 Uridine-13C9 96.8% Unkown
HY-116862 Dibenzylfluorescein 99.54% Unkown
HY-B0113S Omeprazole-d3 Inhibitor 98.99% Unkown
HY-147294 Nivasorexant 99.74% Unkown
HY-144652 IDO1-IN-19 Inhibitor 98.82% Unkown
HY-17356R Fenofibrate (Standard) 99.92% Unkown
HY-B0258R Gemfibrozil (Standard) 99.82% Unkown
HY-N7057S3 Nonanoic acid-d2 98.0% Unkown
HY-W009162S5 Cytidine 5′-monophosphate-13C9,15N3 dilithium 99.80% Unkown
HY-N11222 Nonanoylcarnitine 99.87% Unkown
HY-W587878 Thujopsene 86.31% Unkown
HY-12946 BI 653048 Inhibitor 99.84% Unkown
HY-17356S Fenofibrate-d6 99.70% Unkown
HY-B0113S3 Omeprazole-13C,d3 Inhibitor 98.00% Unkown
HY-N1201S Apigenin-d5 98.90% Unkown
HY-N5132 (-)-Fenchone 98.0% Unkown
HY-Y0123S L-Tyrosine-13C9,15N 98.0% Unkown
HY-107372S2 Uridine triphosphate-13C9 dilithium 99.33% Unkown
HY-161943 NEU3-IN-1 98.74% Unkown
HY-170510 GB2095 Inhibitor 98.92% Unkown
HY-D0184S3 2'-Deoxycytidine-13C9,15N3 98.74% Unkown
HY-N8382 Chalepensin Inhibitor 98.98% Unkown
HY-15550S1 4'-Hydroxy diclofenac-13C6 99.21% Unkown
HY-W018801 5-Nitroisoquinoline 99.38% Unkown
HY-A0070AS1 Liothyronine-13C9,15N / Unkown
HY-W009216S1 2'-Deoxycytidine-5'-monophosphate-13C9,15N3 dilithium 99.8% Unkown
HY-B0258S Gemfibrozil-d6 98.71% Unkown
HY-101399S γ-Glu-(Phe-13C9,15N) / Unkown
HY-107372S Uridine triphosphate-13C9,15N2 sodium / Unkown
HY-124352 2-Nonyl-3-hydroxy-4-quinolone 98.0% Unkown
HY-131495 (S)-6-O-Desmethylnaproxen Inhibitor 95.73% Unkown
HY-138527 Thiol-C9-PEG4 99.06% Unkown
HY-155265 Pomalidomide-5-C9-NH2 hydrochloride 98.68% Unkown
HY-156159 Thalidomide-NH-C9-NH2 hydrochloride Inducer 99.85% Unkown
HY-U00048 Bucolome Inhibitor 98.93% Unkown
HY-W141374 CB096 98.72% Unkown
HY-Z2667 (R)-Esomeprazole Modulator 96.41% Unkown
HY-101399SA γ-Glu-(Phe-13C9,15N) TFA 99.74% Unkown
HY-117160 4-trans-Hydroxy-glibenclamide Inhibitor 99.0% Unkown
HY-132581E Scrambled Tadnersen Control / Unkown
HY-159191S VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA 95.41% Unkown
HY-18063A ML252 hydrochloride Inhibitor 98.5% Unkown
HY-B0158S5 Cytidine-13C9,15N3 98.9% Unkown
HY-N6023 Thermopsoside 98.0% Unkown
HY-172177 ROCK/HDAC-IN-2 / Unkown
HY-13024A Rebastinib tosylate / Unkown
HY-135390 Hydroxy desmethyl Bosentan / Unkown
HY-100386S Ticlopidine-d4 Inhibitor / Unkown
HY-100641S1 4-Hydroxytolbutamide-d9-1 / Unkown
HY-101400S2 Deoxycytidine triphosphate-13C9,15N3 dilithium Activator / Unkown
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / Unkown
HY-101981S3 Uridine 5'-monophosphate-13C9,15N2 dilithium Activator / Unkown
HY-101981S4 Uridine 5'-monophosphate-13C9 dilithium Activator / Unkown
HY-105408A Fandosentan potassium / Unkown
HY-10575 MK-5596 / Unkown
HY-111906 SCYX-6759 Inhibitor / Unkown
HY-113359AS1 Uridine 5'-diphosphate-13C9 dilithium Agonist / Unkown
HY-113400S1 Cytidine diphosphate-13C9 dilithium / Unkown
HY-113400S2 Cytidine diphosphate-13C9,15N3 dilithium 99.7% Unkown
HY-113887 Prostaglandin F1β Agonist / Unkown
HY-113887A 11β-Prostaglandin F1β Control / Unkown
HY-116095 CypD-IN-5 Inhibitor / Unkown
HY-116601 6-Hydroxywarfarin 99.87% Unkown
HY-116811 AZ-11665362 / Unkown
HY-119781 Kaitocephalin Antagonist / Unkown
HY-119996 AR-C141990 Inhibitor / Unkown
HY-121698 GW694481 Inhibitor / Unkown
HY-122163 MK-3901 / Unkown
HY-132581C Scrambled Tadnersen sodium Control / Unkown
HY-13463BS Avatrombopag-d8 hydrochloride Agonist / Unkown
HY-138517 Thiol-C9-PEG7 / Unkown
HY-138526 Thiol-C9-PEG4-acid / Unkown
HY-138528 Thiol-C9-PEG5-acid / Unkown
HY-138529 Thiol-C9-PEG5 / Unkown
HY-138586S DMT-dC(ac) Phosphoramidite-13C9, 15N3 / Unkown
HY-141547 Nav1.7-IN-8 Inhibitor / Unkown
HY-141878 di-Ellipticine-RIBOTAC / Unkown
HY-141878A di-Ellipticine-RIBOTAC TFA / Unkown
HY-141913S 3-Chlorotyrosine-13C9, 15N hydrochloride / Unkown
HY-143906 URAT1 inhibitor 2 Inhibitor / Unkown
HY-145490 trans-Hydroxy Glimepiride / Unkown
HY-147807 HIV-1 inhibitor-40 Inhibitor / Unkown
HY-148597 FGFR-IN-10 Inhibitor / Unkown
HY-149566 Thalidomide-5-O-C9-NH2 hydrochloride Inducer 99.59% Unkown
HY-149572 Thalidomide-4-O-C9-NH2 hydrochloride Inducer 99.26% Unkown
HY-149866 HIV-1 inhibitor-58 Inhibitor / Unkown
HY-150710S Cytidine 5'-triphosphate-13C9,15N3 ammonium / Unkown
HY-151251 CYP2C9/CYP2C19-IN-1 Inhibitor / Unkown
HY-151253 CYP2C1/CYP2C19-IN-2 Inhibitor / Unkown
HY-153371 50-C2-C9-4tail / Unkown
HY-153970 URAT1 inhibitor 7 Inhibitor 98.01% Unkown
HY-156133 Dihydrospinosyn A aglycone / Unkown
HY-159143 BChE-IN-33 Inhibitor / Unkown
HY-160555 (S,R,S)-AHPC-CO-C9-NH2 / Unkown
HY-160555A (S,R,S)-AHPC-CO-C9-NH2 hydrochloride 98.79% Unkown
HY-163208 VH 032 amide-alkylC9-amine hydrochloride / Unkown
HY-163816 Antiproliferative agent-53-d3 Inhibitor / Unkown
HY-164031A Cloperidone hydrochloride Inhibitor / Unkown
HY-164111 JNK-IN-17 Inhibitor / Unkown
HY-166530S Ticlopidine-d6 hydrochloride Inhibitor / Unkown
HY-166934S Endosulfan-13C9 sulfate / Unkown
HY-167872 Bifeprofen Inhibitor / Unkown
HY-168235 (S,R,S)-AHPC-Me-amide-C9-acid Degrader / Unkown
HY-168277 5-Aminothalidomide-C9-Boc / Unkown
HY-169095 (S,R,S)-AHPC-Me-CO-C9-NH2 / Unkown
HY-171722 Ascr#10 Activator / Unkown
HY-171837 c9,t11,c15-CLNA Activator / Unkown
HY-172897 EGFR/DHFR-IN-2 / Unkown
HY-172902 RNA binder 1 / Unkown
HY-173032 VU6033685 Agonist / Unkown
HY-17356G Fenofibrate (GMP) / Unkown
HY-17356S1 Fenofibrate-d4 / Unkown
HY-175447 GDC-0152-amide-PEG2-acid / Unkown
HY-175887 Pomalidomide-C9-Br / Unkown
HY-175977 BnO-CO-O-C9-O-COOH / Unkown
HY-176737 TGF-β1/Smad-IN-1 Inhibitor / Unkown
HY-176905 Tacedinaline-C9-acid / Unkown
HY-177070 Angexostat Inhibitor / Unkown
HY-178479 IDO1-IN-30 / Unkown
HY-178786 RET-IN-31 Inhibitor / Unkown
HY-179154 α-Glucosidase-IN-101 Inhibitor / Unkown
HY-181321 Thalidomide-4-O-C9-Br / Unkown
HY-181611 Polθ-IN-10 / Unkown
HY-181662 DLK-IN-2 Inhibitor / Unkown
HY-181747 CYP11A1-IN-3 Inhibitor / Unkown
HY-182602 KOSN 1724 Inhibitor / Unkown
HY-182890 Thalidomide-5-NH-C9-acid / Unkown
HY-183017 N-Descyclopropanecarbaldehyde olaparib-CO-C9-NHBoc / Unkown
HY-18341S3 L-Thyroxine-13C9,15N / Unkown
HY-184233 C9S Degrader / Unkown
HY-187080 cGAS-IN-5-CH2-amido-C9-NH2 / Unkown
HY-187136 EZH2-IN-13-CO-C9-COOH / Unkown
HY-79131S1 Fmoc-Phe-OH-13C9,15N 99.33% Unkown
HY-B0113S1 Omeprazole-d3-1 Inhibitor 95.09% Unkown
HY-B0153AS Ticlopidine-d4 hydrochloride Inhibitor / Unkown
HY-B1218S Sulfaphenazole-d4 99.66% Unkown
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / Unkown
HY-D0184S5 2'-Deoxycytidine-13C9 96.8% Unkown
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / Unkown
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / Unkown
HY-N0893S Tetrahydrocurcumin-d6 / Unkown
HY-N0904R Ginsenoside C-K (Standard) Inhibitor / Unkown
HY-N1201S1 Apigenin-13C / Unkown
HY-P0073S Tyr-Gly-Gly-{Phe-13C9,15N}-Met-OH TFA / Unkown
HY-P5538S EPYFGYSGAFK-13C9,15N3 TFA / Unkown
HY-RS00534 AKR1C1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01759 C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01760 C9orf72 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01761 C9orf78 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03460 CYP2C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W009216S4 2'-Deoxycytidine-5'-monophosphate-13C9 dilithium 99.5% Unkown
HY-W011090S ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium / Unkown
HY-W015007S Metyrosine-13C9,15N,d7 Inhibitor / Unkown
HY-W018386AS 3-​Bromo-​L-​tyrosine-13C9,15N TFA / Unkown
HY-W018386S1 3-​Bromo-​L-​tyrosine-13C9 / Unkown
HY-W042357S4 Ac-rC Phosphoramidite-13C9 / Unkown
HY-W042357S6 Ac-rC Phosphoramidite-13C9,15N3 / Unkown
HY-W048482S1 rU Phosphoramidite-13C9,15N2 / Unkown
HY-W048482S2 rU Phosphoramidite-13C9 / Unkown
HY-W127393 N-Nonanoyl-L-homoserine lactone / Unkown
HY-W140208 3-Phenylthiophene Inhibitor / Unkown
HY-W663179 DNDI-VL-2098 Inhibitor / Unkown
HY-W707554 Ticlopidine hydrochloride-d6 / Unkown
HY-W753181 (S)-2-Hydroxy-3-phenylpropanoic acid-13C9 / Unkown
HY-117925 Personalised postprandial-targeting Inhibitor / Unkown
HY-124209 9-keto Fluprostenol / Unkown
HY-124352S 2-Nonyl-3-hydroxy-4-quinolone-d4 / Unkown
HY-134999 10-Hydroxywarfarin Inhibitor / Unkown
HY-150712S Uridine triphosphate-13C9,15N2 dilithium / Unkown
HY-164031 Cloperidone Inhibitor / Unkown
HY-169119 Antifungal agent 114 Inhibitor / Unkown
HY-169735 Aurora A inhibitor 4 Inhibitor / Unkown
HY-170367 Antimicrobial agent-35 Inhibitor / Unkown
HY-172335 C9-200 / Unkown
HY-17356S2 Fenofibrate-13C6 / Unkown
HY-175169 Urease-IN-21 Inhibitor / Unkown
HY-178479A (Rac)-IDO1-IN-30 / Unkown
HY-180227 URAT1-IN-15 Inhibitor / Unkown
HY-180273 Antibacterial agent 309 Inhibitor / Unkown
HY-182976 Tenovin-3-CO-C9-NH2 / Unkown
HY-76520S Sitaxsentan-13C6 / Unkown
HY-B0113S2 Omeprazole sulfone (methoxy-d3) Inhibitor 99.70% Unkown
HY-B0113S4 Omeprazole-d3 sodium Inhibitor / Unkown
HY-B0113S5 Omeprazole-d6 Inhibitor / Unkown
HY-B0258S1 Gemfibrozil-d6-1 / Unkown
HY-N12962 11S(12R)-EET / Unkown
HY-N12962A 11R(12S)-EET / Unkown
HY-N7482 Pyranocoumarin / Unkown
HY-P0036S3 Octreotide-13C9,15N / Unkown
HY-RS17317 C9 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20470 Psma4 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21991 C9orf72 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23772 C9 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W008016S Fmoc-Tyr(tBu)-OH-13C9,15N 98.8% Unkown
HY-W009162S1 Cytidine 5′-monophosphate-13C9 dilithium / Unkown
HY-W413619 Cipargamin enantiomer Inhibitor / Unkown
HY-W440809 Nonyl 8-bromooctanoate / Unkown
HY-W753927 9(Z)​,​12(E)​-​Octadecadienoic Acid / Unkown
HY-W800740 Nonyl 6-bromohexanoate / Unkown
HY-113623 Pyrenophorol / Unkown
阻害性抗体 (3)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-P99141 Anti-Mouse LAG-3 Antibody (C9B7W) Inhibitor 99% Unkown
HY-P990140 Anti-Rat β-2-Microglobulin Antibody (4C9) / Unkown
HY-P990204 Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) Inhibitor / Unkown

Orthologs Information

生物種 Symbol 由来 ID
Homo sapiens C9 NCBI NCBI:735